Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes

Gordon, E. R., Kwinta, B. D., Schreidah, C. M., Fahmy, L. M., Adeuyan, O., Queen, D., Trager, M. H., Magro, C. M., & Geskin, L. J. (2023). Cutaneous lymphoproliferative disorders after COVID-19 vaccination: clinical presentation, histopathology, and outcomes. Leukemia & Lymphoma, 65(1), 48–54. https://doi.org/10.1080/10428194.2023.2270766
Authors:
Emily R Gordon
Bradley D Kwinta
Celine M Schreidah
Lauren M Fahmy
Oluwaseyi Adeuyan
Dawn Queen
Megan H Trager
Cynthia M Magro
Larisa J Geskin
Affiliated Authors:
Emily R Gordon
Bradley D Kwinta
Celine M Schreidah
Lauren M Fahmy
Oluwaseyi Adeuyan
Dawn Queen
Megan H Trager
Larisa J Geskin
Columbia Affiliation:
Subjects:
Skin Neoplasms (MeSH)
Lymphomatoid Papulosis (MeSH)
COVID-19 (MeSH)
Skin Diseases (MeSH)
Lymphoproliferative Disorders (MeSH)
Author Keywords:
cd4+ small/medium sized pleomorphic t-cell lymphoproliferative disorder
covid-19 vaccine
cutaneous lymphoproliferative disorder
cutaneous lymphoma
cutaneous reactions
lymphomatoid papulosis
vaccination reaction
vaccine mechanism
vaccine-associated lymphoproliferative disorder
elink
Publication Type:
Article
Unique ID:
10.1080/10428194.2023.2270766
PMID:
37861685
DOI:
10.1080/10428194.2023.2270766
Journal:
Leukemia and Lymphoma
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: